NLRP3 and Parkinson disease: We demonstrated that knockdown of NLPR3 by injection of lentivirus‐coated NLRP3 interference sequence into the SNc could improve 1‐methyl‐4‐phenyl‐1, 2, 3, 6‐tetrahydropyridine (MPTP)‐induced PD‐like symptoms.